Merkley, Sanders, Pallone, Boyle Statement on CBO's Analysis Showing That Trump's Proposed Cuts to NIH, FDA Will Mean Fewer Medications
July 19, 2025
July 19, 2025
WASHINGTON, July 19 -- Sen. Jeff Merkley, D-Oregon, ranking member of the Senate Budget Committee, issued the following news release on July 18, 2025:
* * *
Merkley, Sanders, Pallone, Boyle Statement on CBO's Analysis Showing That Trump's Proposed Cuts to NIH, FDA Will Mean Fewer Medications
Cuts to NIH and FDA Will Lead to 53 Fewer New Prescription Drugs; Trump Administration's Proposed 40 Percent Cut to NIH so Drastic That CBO is Unable to . . .
* * *
Merkley, Sanders, Pallone, Boyle Statement on CBO's Analysis Showing That Trump's Proposed Cuts to NIH, FDA Will Mean Fewer Medications
Cuts to NIH and FDA Will Lead to 53 Fewer New Prescription Drugs; Trump Administration's Proposed 40 Percent Cut to NIH so Drastic That CBO is Unable to . . .